7Vestbo J, Hurd SS, Agustl AG, et al. Global strategy for the diagnosis, man- agement, and prevention of chronic obstructive pulmonary disease: GOLD executive summary [ J ]. Am J Respir Crit Care Med, 2013,187 (4): 347.
8Larsson K, Janson C, Lisspers K, et al. Combination of budesonide/for- moterol more effective than fluticasone/salmeterol inpreventing exacerba- tions inchronic obstructive pulmonary disease: the PATHOS study [ J ]. J In- tern Med,2013,273 (6): 584.
9Molimard M, Le Gros V, Robinson P, et al. Prevalence and associated fac- tors of oropharyngeal side effects in users of inhaled eortieosteroids in a re- al - life setting [ J ]. J Aerosol Med Pulm Drug Deliv, 2010,23 (2) : 91 - 95.
10Irwin RS, Richardson ND. Side effects with inhaled cortieosteroids the physician' s perception[J]. Chest,2006,130( 1 ): 41 - 53.